Back
John B. Sanfilippo & Son, Inc. Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Buy
59
JBSS
John B. Sanfilippo & Son, Inc.
Last Price:
$72.14
Seasonality Move:
7.49%
Buy
67
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$603.30
Seasonality Move:
-5.95%
Buy
59
John B. Sanfilippo & Son, Inc. (JBSS)
is a Buy
Is John B. Sanfilippo & Son, Inc. a Buy, Sell or Hold?
-
The current John B. Sanfilippo & Son, Inc. [JBSS] share price is $72.26. The Score for JBSS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
JBSS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $602.82. The Score for MDGL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JBSS Stock Price Chart
What is John B. Sanfilippo & Son, Inc.'s stock price today?
-
The John B. Sanfilippo & Son, Inc. share price today is $72.26The current trend is moderately bearish and JBSS is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $602.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
JBSS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 49.96 | Sell |
| Chaikin Money Flow: | -11685 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.72 - 75) | Sell |
| Bollinger Bands (100): | (61.67 - 70.63) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.24 | Buy |
| Relative Strength Index (14 RSI): | 65.56 | Buy |
| Chaikin Money Flow: | -80962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (553.78 - 593.58) | Buy |
| Bollinger Bands (100): | (394.99 - 540.89) | Buy |
JBSS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.7 | Sell |
| 20-day SMA: | 73.52 | Sell |
| 50-day SMA: | 68.72 | Buy |
| 200-day SMA: | 65.89 | Buy |
| 8-day EMA: | 73.66 | Sell |
| 20-day EMA: | 73.03 | Sell |
| 50-day EMA: | 70.14 | Buy |
| 200-day EMA: | 69.53 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 575.58 | Buy |
| 20-day SMA: | 575.82 | Buy |
| 50-day SMA: | 519.09 | Buy |
| 200-day SMA: | 387.01 | Buy |
| 8-day EMA: | 584.59 | Buy |
| 20-day EMA: | 569.79 | Buy |
| 50-day EMA: | 529.81 | Buy |
| 200-day EMA: | 417.14 | Buy |
John B. Sanfilippo & Son, Inc. Earnings Growth & JBSS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.37 per share, and an increase next year of $12.54 per share.
John B. Sanfilippo & Son, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||